{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:04:32Z","timestamp":1787061872196,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.idc.2018.05.002","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T02:20:46Z","timestamp":1534990846000},"page":"703-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients"],"prefix":"10.1016","volume":"32","author":[{"given":"David J.","family":"Epstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna K.","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.idc.2018.05.002_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0002-9343(67)90260-4","article-title":"Death after transplantation; an analysis of sixty cases","volume":"42","author":"Hill","year":"1967","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.idc.2018.05.002_bib2","first-page":"677","article-title":"Miliary tuberculosis in a renal transplant recipient","volume":"108","author":"Neff","year":"1973","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"10.1016\/j.idc.2018.05.002_bib3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1399-3062.2012.00737.x","article-title":"Impact of pulmonary and extrapulmonary tuberculosis infection in kidney transplantation: a nationwide population-based study in Taiwan","volume":"14","author":"Ou","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.idc.2018.05.002_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.12659\/AOT.883882","article-title":"Risk factors and characteristics of post-transplant tuberculosis in an endemic area","volume":"18","author":"Joo","year":"2013","journal-title":"Ann Transplant"},{"issue":"12","key":"10.1016\/j.idc.2018.05.002_bib5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"RR-11","key":"10.1016\/j.idc.2018.05.002_bib6","first-page":"19","article-title":"Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the advisory council for the elimination of tuberculosis","volume":"44","year":"1995","journal-title":"MMWR Recomm Rep"},{"issue":"RR-6","key":"10.1016\/j.idc.2018.05.002_bib7","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"10.1016\/j.idc.2018.05.002_bib8","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/599035","article-title":"Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort","volume":"48","author":"Torre-Cisneros","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2018.05.002_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5588\/ijtld.11.0259","article-title":"Pre-transplant risk factors for tuberculosis after kidney transplant in an intermediate burden area","volume":"16","author":"Jung","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.idc.2018.05.002_bib10","doi-asserted-by":"crossref","first-page":"E169","DOI":"10.1111\/ctr.12077","article-title":"Clinical features and outcomes of tuberculosis in kidney transplant recipients in Brazil: a report of the last decade","volume":"27","author":"Marques","year":"2013","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.idc.2018.05.002_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.transproceed.2013.11.108","article-title":"Utility of QuantiFERON-TB assay for prediction of tuberculosis development in kidney transplant patients in an intermediate-tuberculosis-burden country: lack of evidence for enhanced prediction for short-term tuberculosis development","volume":"46","author":"Jeong","year":"2014","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.idc.2018.05.002_bib12","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/ajt.13235","article-title":"Incidence and risk factors for tuberculosis after liver transplantation in an endemic area: a nationwide population-based matched cohort study","volume":"15","author":"Chen","year":"2015","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.idc.2018.05.002_bib13","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/tid.12555","article-title":"Risk of tuberculosis after lung transplantation: the value of pretransplant chest computed tomography and the impact of mTOR inhibitors and azathioprine use","volume":"18","author":"Guirao-Arrabal","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2018.05.002_bib14","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1600-6143.2007.02011.x","article-title":"Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation","volume":"7","author":"Manuel","year":"2007","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.idc.2018.05.002_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1378\/chest.08-2575","article-title":"Performance of tests for latent tuberculosis in different groups of immunocompromised patients","volume":"136","author":"Richeldi","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.idc.2018.05.002_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-3062.2010.00495.x","article-title":"Diagnostic usefulness of a T\u00a0cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation","volume":"12","author":"Kim","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2018.05.002_bib17","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/ndt\/gfr516","article-title":"Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?","volume":"27","author":"Soysal","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.idc.2018.05.002_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/tid.12027","article-title":"QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TB","volume":"15","author":"Ahmadinejad","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2018.05.002_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s15010-012-0291-0","article-title":"Comparison of the tuberculin skin test and interferon-gamma release assay for the diagnosis of latent tuberculosis infection before kidney transplantation","volume":"41","author":"Kim","year":"2013","journal-title":"Infection"},{"issue":"10","key":"10.1016\/j.idc.2018.05.002_bib20","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.idc.2018.05.002_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tid.12675","article-title":"Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients","volume":"19","author":"Edathodu","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2018.05.002_bib22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/TP.0000000000000451","article-title":"The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis","volume":"99","author":"Ferguson","year":"2015","journal-title":"Transplantation"},{"issue":"RR-5","key":"10.1016\/j.idc.2018.05.002_bib23","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"10.1016\/j.idc.2018.05.002_bib24","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/j.1600-6143.2011.03625.x","article-title":"A\u00a0prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients","volume":"11","author":"Kim","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.idc.2018.05.002_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/1471-2334-14-387","article-title":"The risk factors for tuberculosis in liver or kidney transplant recipients","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2018.05.002_bib26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/lt.22319","article-title":"Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates","volume":"17","author":"Lyu","year":"2011","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.idc.2018.05.002_bib27","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1378\/chest.09-1513","article-title":"The role of chest CT scanning in TB outbreak investigation","volume":"137","author":"Lee","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.idc.2018.05.002_bib28","unstructured":"Centers for Disease Control and Prevention: Division of tuberculosis elimination. Latent tuberculosis infection: a guide for primary health care providers, treatment of latent TB infection. 2016. Available at: http:\/\/www.cdc.gov\/tb\/publications\/ltbi\/treatment.htm Accessed February 12, 2017."},{"issue":"3","key":"10.1016\/j.idc.2018.05.002_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ctr.12901","article-title":"Efficacy and safety of short-term treatment with isoniazid and rifampicin for latent tuberculosis infection in lung transplant candidates","volume":"31","author":"Guirao-Arrabal","year":"2017","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.idc.2018.05.002_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/520983","article-title":"The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study","volume":"45","author":"Spyridis","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2018.05.002_bib31","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/civ156","article-title":"Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial","volume":"60","author":"Torre-Cisneros","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2018.05.002_bib32","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5588\/ijtld.13.0028","article-title":"Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012","volume":"18","author":"Bamrah","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"10.1016\/j.idc.2018.05.002_bib33","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/cid\/cix208","article-title":"Systematic review, meta-analysis, and cost-effectiveness of treatment of latent tuberculosis to reduce progression to multidrug-resistant tuberculosis","volume":"64","author":"Marks","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.05.002_bib34","unstructured":"New York City Department of Health and Mental Hygiene: Bureau of Tuberculosis Control. Clinical Policies and Protocols. 2008. Available at: http:\/\/www1.nyc.gov\/assets\/doh\/downloads\/pdf\/tb\/tb-protocol.pdf. Accessed March 12, 2017."},{"issue":"3","key":"10.1016\/j.idc.2018.05.002_bib35","article-title":"Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis","author":"Adamu","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.idc.2018.05.002_bib36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-149-10-200811180-00003","article-title":"Adverse events with 4\u00a0months of rifampin therapy or 9\u00a0months of isoniazid therapy for latent tuberculosis infection: a randomized trial","volume":"149","author":"Menzies","year":"2008","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.idc.2018.05.002_bib37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.5588\/ijtld.11.0504","article-title":"Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial","volume":"16","author":"Chan","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"10.1016\/j.idc.2018.05.002_bib38","article-title":"Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB","author":"Sharma","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.idc.2018.05.002_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7326\/M14-1019","article-title":"Treatment of latent tuberculosis infection: a network meta-analysis","volume":"161","author":"Stagg","year":"2014","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2018.05.002_bib40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cid\/civ323","article-title":"Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid or daily isoniazid for treatment of latent tuberculosis infection in the PREVENT tuberculosis study","volume":"61","author":"Sterling","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2018.05.002_bib41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/M17-1150","article-title":"Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial","volume":"167","author":"Belknap","year":"2017","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.idc.2018.05.002_bib42","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archinte.162.9.985","article-title":"Rifampin and rifabutin drug interactions: an update","volume":"162","author":"Finch","year":"2002","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.idc.2018.05.002_bib43","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.idc.2018.05.002_bib44","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/01.tp.0000266578.45634.4f","article-title":"Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period","volume":"83","author":"Jahng","year":"2007","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.idc.2018.05.002_bib45","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00007890-200209270-00029","article-title":"Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis","volume":"74","author":"Singh","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.idc.2018.05.002_bib46","doi-asserted-by":"crossref","first-page":"338","DOI":"10.12659\/AOT.902989","article-title":"Isoniazid prophylaxis for latent tuberculosis infections in liver transplant recipients in a tuberculosis-endemic area","volume":"22","author":"Moon","year":"2017","journal-title":"Ann Transplant"},{"issue":"4","key":"10.1016\/j.idc.2018.05.002_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/lt.23622","article-title":"Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation","volume":"19","author":"Hickey","year":"2013","journal-title":"Liver Transpl"},{"issue":"48","key":"10.1016\/j.idc.2018.05.002_bib48","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.idc.2018.05.002_bib49","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/cid\/civ639","article-title":"Tolerability of fluoroquinolones in management of latent tuberculosis in liver transplant candidates","volume":"61","author":"Tien","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2018.05.002_bib50","first-page":"251","article-title":"Tuberculosis transmitted through transplantation","volume":"43","author":"Graham","year":"2001","journal-title":"J\u00a0Infect"},{"issue":"11","key":"10.1016\/j.idc.2018.05.002_bib51","first-page":"1493","article-title":"Multi-recipient donor-transmitted tuberculosis","volume":"14","author":"Edathodu","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"10.1016\/j.idc.2018.05.002_bib52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijmm.2013.06.005","article-title":"First case of Mycobacterium tuberculosis transmission by heart transplantation from donor to recipient","volume":"303","author":"Weile","year":"2013","journal-title":"Int J Med Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2018.05.002_bib53","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/tid.12580","article-title":"Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection","volume":"18","author":"Jensen","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2018.05.002_bib54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s15010-015-0853-z","article-title":"Donor-derived tuberculosis after solid organ transplantation in two patients and a staff member","volume":"44","author":"Bucher","year":"2016","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.idc.2018.05.002_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/tid.12171","article-title":"Three cases of donor-derived pulmonary tuberculosis in lung transplant recipients and review of 12 previously reported cases: opportunities for early diagnosis and prevention","volume":"16","author":"Mortensen","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2018.05.002_bib56","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1111\/j.1600-6143.2012.04205.x","article-title":"Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report","volume":"12","author":"Morris","year":"2012","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.idc.2018.05.002_bib57","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.tp.0000188689.41785.d8","article-title":"Screening for tuberculosis in the study of the living renal donor in a developing country","volume":"81","author":"Hernandez-Hernandez","year":"2006","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.idc.2018.05.002_bib58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12882-017-0506-9","article-title":"Poor predictability of QuantiFERON-TB assay in recipients and donors for tuberculosis development after kidney transplantation in an intermediate-TB-burden country","volume":"18","author":"Jambaldorj","year":"2017","journal-title":"BMC Nephrol"},{"issue":"9","key":"10.1016\/j.idc.2018.05.002_bib59","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.transproceed.2012.09.060","article-title":"Clinical features and outcomes of tuberculosis in solid organ transplant recipients","volume":"44","author":"Bodro","year":"2012","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.idc.2018.05.002_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1399-3062.2011.00680.x","article-title":"Clinical features and risk factors of tuberculosis in living-donor liver transplant recipients","volume":"14","author":"Imai","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2018.05.002_bib61","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/tri.12752","article-title":"Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients","volume":"29","author":"Yoo","year":"2016","journal-title":"Transpl Int"},{"issue":"6","key":"10.1016\/j.idc.2018.05.002_bib62","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1469-0691.2003.00532.x","article-title":"Mycobacterial infection in a series of 1261 renal transplant recipients","volume":"9","author":"Queipo","year":"2003","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.idc.2018.05.002_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tid.12750","article-title":"Tuberculosis after kidney transplantation is associated with significantly impaired allograft function","volume":"19","author":"Costa","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2018.05.002_bib64","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1399-0012.2008.00878.x","article-title":"Tuberculosis in southern Chinese renal-transplant recipients","volume":"22","author":"Chen","year":"2008","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.idc.2018.05.002_bib65","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/tid.12501","article-title":"Epidemiology of tuberculosis after kidney transplantation in a developing country","volume":"18","author":"Meinerz","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2018.05.002_bib66","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1093\/ndt\/gfr156","article-title":"Tuberculosis following kidney transplantation: clinical features and outcome. A French multicentre experience in the last 20 years","volume":"26","author":"Canet","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.idc.2018.05.002_bib67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-3062.2009.00475.x","article-title":"Tuberculosis following solid organ transplantation","volume":"12","author":"Lopez de Castilla","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2018.05.002_bib68","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ndt\/gfh691","article-title":"Tuberculosis in renal transplant recipients on various immunosuppressive regimens","volume":"20","author":"Atasever","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.idc.2018.05.002_bib69","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.transproceed.2009.01.075","article-title":"Tuberculosis in renal transplant recipients: a Brazilian center registry","volume":"41","author":"Guida","year":"2009","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.idc.2018.05.002_bib70","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1399-3062.2012.00721.x","article-title":"Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients","volume":"14","author":"Ha","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"15","key":"10.1016\/j.idc.2018.05.002_bib71","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"30","key":"10.1016\/j.idc.2018.05.002_bib72","doi-asserted-by":"crossref","first-page":"801","DOI":"10.15585\/mmwr.mm6630a1","article-title":"Solid organ transplant-transmitted tuberculosis linked to a community outbreak - California, 2015","volume":"66","author":"Kay","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.idc.2018.05.002_bib73","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2018.05.002_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/00912709922007499","article-title":"Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers","volume":"39","author":"Hebert","year":"1999","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.idc.2018.05.002_bib75","unstructured":"Drug-resistant tuberculosis: a survival guide for clinicians. 3rd edition. 2016. Available at: http:\/\/www.currytbcenter.ucsf.edu\/products\/drug-resistant-tuberculosis-survivalguide-clinicians-3rd-edition. Accessed March 12, 2017."},{"issue":"9","key":"10.1016\/j.idc.2018.05.002_bib76","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/00007890-200105150-00001","article-title":"Guidelines for the referral and management of patients eligible for solid organ transplantation","volume":"71","author":"Steinman","year":"2001","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.idc.2018.05.002_bib77","first-page":"1039","article-title":"Living-donor liver transplantation in patients with concurrent active tuberculosis at transplantation","volume":"14","author":"Lee","year":"2010","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552018300515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552018300515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T02:21:29Z","timestamp":1534990889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552018300515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0891552018300515"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2018.05.002","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2018.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}